CVE-2009-4324
Published: June 8, 2022
Official Description
Use-after-free vulnerability in Adobe Acrobat and Reader allows remote attackers to execute code via a crafted PDF file.
CISA KEV Advisory
Adobe Acrobat and Reader Use-After-Free Vulnerability
Use-after-free vulnerability in Adobe Acrobat and Reader allows remote attackers to execute code via a crafted PDF file.
Apply updates per vendor instructions.
Risk Analysis
A use-after-free vulnerability in Adobe Acrobat and Reader allows remote attackers to execute arbitrary code via a specially crafted PDF file. The high EPSS score of 0.93013 indicates a strong likelihood of exploitation, and its inclusion in CISA's KEV catalog confirms it is actively being exploited. This poses a significant risk to users of these products.
This vulnerability is actively exploited in the wild, indicating that attackers are leveraging it to compromise systems. The flaw is remotely exploitable, typically through malicious PDF files.
Apply the latest security updates and patches for Adobe Acrobat and Reader. Exercise caution when opening untrusted PDF files and ensure that PDF readers are configured with enhanced security settings, such as Protected View.
Technical Analysis
CVE-2009-4324 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CISA has added CVE-2009-4324 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.
Affected Vendors & Products
Exploit & PoC Resources
All References (1)
Quick Facts
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2009-4324 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
- !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
- !Active exploitation confirmed — treat as P1